Eosinophils, purified from BAL fluid of OVA-sensitized and -challenged wild-type or LTC4S−/− mice, were resuspended at a concentration of 1 × 106 cells/ml in RPMI 1640 with 0.1% OVA, 24 mM HEPES, and 2 mM glutamine and pre-incubated for 30 minutes with LTC4 (200 nM) or control medium. Transwell permeable supports containing polycarbonate membranes with 5 µm pores were used (Corning, Lowell, MA). The lower chambers below the transwell contained 600 µl of RPMI-1640 containing 0.2% bovine serum albumin with or without recombinant CCL19 or CCL21 (R&D Systems, Minneapolis, MN) or sphingosine-1-phosphate (Sigma). Eosinophil suspensions (100 µl) were added to the upper chamber. Wells were set up in triplicate for each experiment. Chemotaxis plates were incubated at 37°C for 2 hours. Migrating cells in the lower chamber were counted for 15 seconds in triplicate by flow cytometry.
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.